Cost vs Clinical Need: Understanding the Economic Outlook and Affordability Challenges Facing Albumin Therapy in the US Healthcare System
The **US Albumin Market Economic Outlook** is characterized by a high intrinsic demand juxtaposed with significant cost and supply chain challenges Albumin, especially the plasma-derived variety, is an expensive product due to the rigorous, capital-intensive nature of its production The multi-step plasma fractionation process requires highly specialized equipment, stringent quality...
0 Comments 0 Shares 319 Views 0 Reviews